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asthma control in pregnancies complicated by
asthma: study protocol for a randomized
controlled trial
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Abstract
Background: Asthma is the most prevalent chronic disease to complicate pregnancies worldwide, affecting
around 12% of pregnant women in Australia. Oxidative stress and inflammation manifest during pregnancy;
however asthma in pregnancies further intensifies oxidative stress. Consumption of antioxidant-rich foods has been
shown to be beneficial for asthma control in non-pregnant asthmatic adults. It has not been investigated whether
antioxidant-rich foods can improve the elevated oxidative stress that occurs with asthma in pregnancy, thereby
improving asthma control. The primary aim of this study is to determine whether increased consumption of
antioxidant-rich foods for 12 weeks will improve maternal asthma control, compared to standard dietary intake
during pregnancy.
Methods/design: A 12 week, parallel randomized controlled trial will be conducted. One hundred and sixty eight
pregnant women with mild, moderate, or severe asthma, currently using inhaled corticosteroids, and with poor
diet quality, will be recruited at approximately12 weeks gestation. Following a 4 week run-in period, women will
be randomized to either a 12 week antioxidant intervention (increased consumption of antioxidant-rich foods
(≥5 servings/day vegetables, ≥2 servings/day fruit, ≥8 ½ servings/day grains (mostly wholegrains), 3–4 serving/week
lean meat) or standard pregnancy care. The primary outcome is asthma control score (decrease of 0.5, the minimally
clinically significant change). Secondary outcomes include plasma antioxidants, markers of oxidative stress, and
time to, and number of, exacerbations. With two-tailed t-tests at 80% power, a sample size of 52 completions
per group is required. Allowing for a 78% retention including a 20% removal of women from the analysis due to
non-compliance, we will recruit 168 women.
Discussion: It is expected that this 12 week study will improve asthma control. This is significant because asthma
is the most prevalent condition to complicate pregnancies and contributes to poor maternal, neonatal and infant
health outcomes. Our research will provide the first evidence to show that, in pregnancy, consumption of
antioxidant-rich foods is a key modifier of clinical asthma status. This research is crucial for contributing to the
evidence base to inform future guidelines given existing clinical and research gaps.
Trial registration: ACTRN12613000301763
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Background
Asthma is a chronic and complex inflammatory disease
of the airways with symptoms including excess mucus
production, wheeze, dyspnea, cough, fatigue, anxiety,
tachycardia, and chest tightness. Oxidative stress plays a
role in asthma etiology due to activation of various
inflammatory cells of the respiratory tract such as neutro-
phils, eosinophils, mast cells and lymphocytes [1]. The
continuous exposure of the respiratory tract to environ-
mental oxidants and airway inflammatory cell-generated
reactive oxygen species creates a high level of oxidative
stress in the lung [2,3].
The lungs have endogenous antioxidant mechanisms to
combat the damaging effects of reactive oxygen species;
however, levels of antioxidants in the lungs as well as in
circulation are reduced in asthmatic patients [4-6]. Wood
et al. established for the first time that in adults with
asthma, α-tocopherol levels were reduced in subjects with
severe disease compared with those with a mild-to-
moderate asthma pattern; α-tocopherol levels were also
reduced in those with airway hyper-responsiveness; and in
patients with stable, but poorly controlled asthma, antio-
xidant potential was lower compared with those with
controlled or partly controlled asthma [7]. Other human
mechanistic studies have shown that the airway epithe-
lium in asthmatic adults is more susceptible to oxidants
than in non-asthmatic adults [8], and Zalewski et al. iden-
tified lower labile sputum zinc levels that were associated
with increased frequency of wheeze, asthma severity and
reduced lung function [9]. In an intervention study, asth-
matic subjects who withdrew antioxidant-rich foods from
their diet for 10 days, including limiting fruit (≤1 serving/d)
and vegetable (≤2 servings/d) intake (n = 22), had reduced
plasma carotenoids, increased sputum neutrophils and
poorer lung function and asthma control [10]. Compara-
tively, increasing dietary intakes of carotenoids, through
increased consumption of fruit (≥2 servings/d) and vegeta-
bles (≥5 servings/d) for 14 weeks was shown to positively
affect clinical asthma outcomes in adults with asthma, by
reducing the risk of asthma exacerbation [11]. Importantly,
improvements in asthma control only occurred after in-
creased intake of fruit and vegetables, whereas no improve-
ments in asthma outcomes were identified following 14
weeks of lycopene supplementation [10]. Other studies
assessing single antioxidant supplementation in asthmatic
adults do not provide support for improving asthma out-
comes [12-14]. Therefore, dietary modification through
whole foods appears a valuable strategy for improving
outcomes associated with asthma.
Asthma is the most prevalent chronic disease to com-
plicate pregnancies worldwide, with prevalence between
8 and 13% [15-17]. In Australia, about 12% of pregnant
women have asthma, and 35% of these women report
that their asthma worsens during pregnancy [16]. Clifton
et al. identified that asthma in pregnancy increases risk
of low birth weight, small-for-gestational-age (SGA) ba-
bies, preterm delivery and preeclampsia [18]. Asthma ex-
acerbation is frequent, even in mild asthma; this has
been linked to increased risk of low birth weight [19].
Oxidative stress is manifested at the maternal-fetal
interface and contributes to normal placental develop-
ment. The progression of pregnancy increases the activa-
tion of several maternal oxidative stress and inflammatory
pathways [20] and compared to the non-pregnant state,
markers of oxidative stress are higher [21]. In addition, the
placenta is believed to be a major source of free radicals
and lipid peroxide production [21], leading to systemic
oxidative stress during gestation and delivery. Generally,
pregnant women cope with these physiologic changes
which are controlled by an increase in antioxidant enzyme
activity [22,23]. Asthma during pregnancy has been asso-
ciated with increased markers of oxidative stress, inde-
pendent of asthma severity or treatment [24] and may
promote the worsening of asthma through systemic
inflammation and local production of chemokines from
airway cells [25].
Maternal nutrition has the potential to influence fetal
growth, as well as immune and airway development.
However, there has been a shift from higher consump-
tion of traditional plant-based foods to diets higher in
processed foods [26]. This increased intake of processed
foods and higher intake of fat, specifically saturated fat,
and sugar, parallels the reduced intake of fruits and
vegetables that contain antioxidants [27,28]. Poor diet
quality during pregnancy has been associated with adverse
fetal and childhood outcomes: a low intake of fruit and
vegetables increased the odds of childhood wheeze [29]
and a high intake of butter and butter spreads increases
risk of childhood rhinitis [30]. Comparatively, dietary pat-
terns that include higher intakes of fruit and vegetables
are associated with reduced odds for growth restriction
[31] and SGA babies [32,33]. Supplementation studies
assessing multiple micronutrients [34], vitamin D [35],
vitamins B or C [36], vitamins E or C [37,38] or vitamin A
[39] did not improve maternal or perinatal outcomes (for
example, preterm birth, low birth weight, perinatal mor-
bidity, or preeclampsia). Other studies have suggested
vitamin E supplementation might adversely affect mater-
nal health [40] and an antioxidant supplement might
increase risk of preterm delivery [41]. Altering food intake
patterns towards an antioxidant-rich diet, which is also
fiber-rich and low in fat, might be protective in asthma.
There are few studies of dietary intake in pregnant
women with asthma. One study found that pregnant
asthmatic women with low circulating concentrations of
individual antioxidants had poorer fetal growth outcomes
such as head circumference and birth weight, but no asso-
ciations were found for non-asthmatic women [42]. These
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data suggest a link between poor perinatal outcomes and
maternal antioxidant status. Interventions aimed at im-
proving asthma control and that might subsequently
impact perinatal outcomes deserve investigation.
Improving antioxidant status and relieving the oxida-
tive stress that occurs with pregnancy is likely to have a
beneficial effect. Nutritional strategies that can lower
maternal oxidative stress may premise for preventing the
asthma burden in pregnancy. Given the often poor dietary
intakes during pregnancy, the increasing rate of pregnan-
cies complicated by asthma, and the prevalence of adverse
maternal and fetal outcomes among pregnant women with
asthma, it is timely to intervene in this population with
antioxidant-rich foods. Pregnancy is considered a key time
for dietary modification, as several adaptations take place
in which additional nutrients are needed to support devel-
opment. Currently, it has not been investigated whether
increasing consumption of antioxidant-rich foods, in preg-
nant women with asthma, will demonstrate improvements
in asthma control. The potential for diets containing
antioxidants to increase maternal antioxidant defence
provides a valuable strategy that could subsequently
reduce oxidative stress and improve asthma control.
Improved diet in combination with asthma management
and treatment will improve asthma control and therefore
improve fetal outcomes.
The aims of the proposed research are to determine,
in pregnant women with asthma, whether 12 weeks
consumption of antioxidant-rich foods (≥5 servings/d
vegetables, ≥2 servings/d fruit, ≥8½ servings/d grains
(mostly wholegrains), 3 to 4 servings/week lean meat))
which meets nutrient requirements during pregnancy
will: 1) improve asthma control; 2) improve antioxidant
concentrations, and reduce markers of oxidative stress and
inflammation, and 3) reduce the risk of asthma exacerba-
tion, compared to standard dietary care during pregnancy.
Methods/design
Study design
We will conduct a 12-week, parallel randomized con-
trolled trial (RCT). Pregnant women with asthma will
be randomly allocated to either 1) an antioxidant-rich
diet (that is, increased consumption of foods contain-
ing antioxidants; ≥5 servings/d vegetables, ≥2 servings/d
fruit, ≥8½ servings/d grains (mostly wholegrains), 3 to
4 servings/week lean meat, or 2) standard care during
pregnancy.
Ethics and trial registration
Ethics approval for this study was granted by the Human
Research Ethics Committee (TQEH/LMH/MH) (project:
HREC/13/TQEHLMH/200). The trial was registered on
the Australia and New Zealand Clinical Trials registry
(ANZCTR) on 19 March 2013 (ANZCTR Number:
ACTRN12613000301763).
Participants
Pregnant women will be recruited from Lyell McEwin
Hospital (LMH), Adelaide, Australia. The LMH is situ-
ated in a region of lower socioeconomic status, as deter-
mined by the South Australian Health Atlas. Inclusion
criteria are as follows: pregnant women with mild, moder-
ate, or severe asthma and currently using inhaled corti-
costeroids (ICS) (see Assessment of asthma below); >18
years of age, and poor diet quality (<3 servings/d fruit and
vegetable). Exclusion criteria are as follows: recent (past
month) respiratory tract infection; intermittent asthma;
current smoker; use of antioxidant supplements, or previ-
ous pregnancy complications including growth restriction,
stillbirth or preterm delivery.
Protocol
At approximately 12 weeks gestation (range 10 to 14
weeks), asthmatic women will be recruited to participate
(Figure 1) in the 12-week intervention study, with an
initial 4-week run-in period (Table 1). At this initial visit,
women will have the study procedures explained and have
their asthma assessed (described below). A telephone call
to determine consent will be made at approximately 13
weeks gestation in which a date to start the subsequent
run-in period will be made. Signed consent forms will be
obtained at the 14 weeks gestation visit. At this visit, the
run-in period will commence where the women will be
provided individual asthma management and education,
complete a questionnaire on how/if their food intake has
changed since learning they were pregnant, and will
complete a food frequency questionnaire (FFQ). At 18
weeks gestation (that is, the baseline visit), women will be
randomized into a control or intervention group (Table 1).
At this baseline visit, weight and blood pressure will be
measured, a fetal scan performed, questionnaires on
asthma control, physical activity, and smoking will be
completed, a blood sample taken, and dietary information
collected. The same measurements will occur at 24 and
30 weeks gestation for all women. Phone calls will be
made at 20, 22, 26 and 28 weeks gestation for information
on asthma control and dietary intakes, and women in
the intervention group will receive additional dietary
counseling and support regarding the consumption of
antioxidant-rich foods. At 30 weeks gestation, both groups
will come back to the clinic for their final visit (Table 1).
At delivery, birth outcomes will be assessed.
The control group will receive only the standard-care
LMH pregnancy booklet, Healthy Eating During Preg-
nancy. The booklet contains the recommended number of
servings of each food group to be consumed in pregnancy,
according to the 2013 Australian Dietary Guidelines




131014.pdf), as well as further information on key nutri-
ents during pregnancy, supplements, weight gain during
pregnancy, and guidance on, for example, alcohol, caffeine
and water intake, and listeria, as referenced from SA
Health; RANZCOG 2009; Noarlunga Health Services;
and Food Standards, Australia and New Zealand. No
additional dietary education will be provided to the
control group.
The intervention group will receive the same booklet;
however, the group will be further counseled on types of
antioxidant-rich foods to purchase and consume such as
fruits (for increasing intake of carotenoids, vitamins A
and C), vegetables (carotenoids, vitamins A and C),
wholegrains (vitamin E, selenium) and lean meat (zinc,
iron, long chain omega 3 fatty acids) over the 12-week
study. Examples of types of foods to consume will also
be provided: for example, choosing spinach leaves instead
of lettuce, and sweet potato instead of white potato.
Women will be provided with a list of foods that are high
in antioxidants, and will be asked to identify which types
of these foods they are most likely to purchase and con-
sume over the 12 weeks. Women in this group will also be
given meal/snack suggestions to assist compliance. Previ-
ous pilot work from the authors has identified, in a dietary
pattern analysis, that a high fat/sugar/takeaway pattern
was evident in this population of pregnant women with
high consumption of takeaway foods, crisps, refined grains
and cakes and limited consumption of fruits and vegeta-
bles. Therefore, a shopping voucher of $30 per week per
intervention participant will be provided, which will con-
tribute to the cost spent on fruits and vegetables, as well
as wholegrains and lean meats.
Assessment of asthma and asthma outcomes
Women attending their first booking visit at the LMH
antenatal clinic will be identified with asthma by the
Approximately 12 weeks gestationa: 
Recruitment and assessment of 
eligibility
Excluded




Allocated to antioxidant intervention
Dietary education
Approximately 30 weeks gestation: 
Post intervention clinic assessments 
Allocated to standard dietary care





Approximately 24 weeks gestation: 
Mid-study clinic assessments
Fortnightly phone-calls
Figure 1 Flow diagram of the progress through the phases of the randomized controlled trial. aWomen attending their first antenatal visit
at 10 to 14 weeks gestation will be recruited. The run-in phase and intervention will start 2 weeks and 4 weeks following recruitment and consent.
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attending midwife. To determine asthma, the midwife
will ask, ‘Have you been told by a doctor that you have
asthma?ʼ and ‘Have you used any asthma medications in
the last year like Ventolin or a preventer?’ Interested
asthmatic women will have the study explained with
written and verbal information by the research midwife.
At 14 weeks gestation, women will come back to the
clinic to start the run-in phase in which they will have
an asthma assessment determined by current asthma
therapy and control, current asthma triggers and comor-
bidity and past history including frequency of oral
corticosteroid use and previous hospital admissions for
asthma. At this first visit, all women will undergo
spirometry to assess lung function before and after
salbutamol use. Measurements will be taken by a trained
respiratory nurse. Blood will be drawn for a full blood
count and total IgE to assess atopy.
Asthma control
Asthma control will be assessed using the standard
asthma control questionnaire 6 (ACQ6) [43] administered
by the respiratory nurse. Controlled asthma will be
defined as ACQ <0.75, partly controlled asthma will be
defined as 0.75 to <1.5, and uncontrolled asthma will
be defined as ACQ >1.5 [43]. Information on evidence of
infections, cold or flu will be obtained using the common-
cold questionnaire [44] at each visit. Asthma severity will
be classified based on their current symptoms as mild,
moderate or severe [45]. Exacerbations prior to the visit
will be assessed by noting unscheduled doctors’ visits,
increases in medication requirements, emergency depart-
ment visits, or hospitalizations.
Fractional exhaled nitric oxide (FENO)
FENO measures airway inflammation and asthma
control (NIOX, Aerocline, Solan, Sweden). We will meas-
ure FENO at a controlled flow rate of 50 mL/s according
to the American Thoracic Society guidelines, and as
reported in Murphy et al. [46].
Asthma management and education(AME)
Standard management of asthma will be carried out by
the respiratory nurse [47,48]. At the run-in phase, all
asthmatic women will be provided information on how
to manage their asthma, and be given asthma education
and advice. This 30-minute session will include skills
assessment (medication adherence, inhaler device tech-
nique); development of a written asthma action plan and
advice on trigger avoidance, and education about asthma
control. It is important that the women in the study
receive this, as previous data obtained from LMH
indicate that 16% of pregnant women have asthma and
it is often poorly controlled, leading to high exacerbation
rates. Women assessed as unstable and requiring
Table 1 Study endpoints and procedures for the intervention and control groups
Week of gestation 12 14 (n = 168) 16 18 20 22 24 26 28 30 (n = 104)
Endpoint Recruit Run-in Randomization and intervention End
Clinic
Height X
Weight X X X X
Blood pressure X X X X
Fetal scan X X X
FFQ X
24-hr recall X X X X
Blood X X X X
AME X X
ACQ6 X X X X X
FENO X X X X
Questionnairesa X X X
Food group count X X X X
Telephone
ACQ6 X X X X X
Food group count X X X X X
24-hr recall X X X X X
FFQ, food frequency questionnaire; AME, asthma management and education; ACQ6, asthma-control questionnaire 6; FENO, fraction of exhaled nitric oxide.
aQuestionnaires include: eating habits subscale, common-cold questionnaire, passive-smoking questionnaire and physical-activity questionnaire.
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medical review will be referred to a respiratory phys-
ician. Urgent medical review will be available for patients
with an acute exacerbation. Women will be encouraged
to see their family doctor if their asthma worsens and gen-
eral practitioners (GPs) will receive information relating to
the study so that they are aware of its purpose.
Maternal and perinatal characteristics
Maternal height, weight, age, weight gain, blood pressure,
parity and gravidity will be recorded. Socioeconomic
status will be collected, including postcode, maternal edu-
cation and occupation, marital status and paternal educa-
tion and occupation (if available). Labor information will
be collected and neonatal data will be collected at delivery,
including gestational age at delivery, birth weight, length,
head circumference, Apgar scores and any congenital
abnormalities. Birth-weight centiles will be calculated
using www.gestation.net. Fetal birth weight will be catego-
rized as low birth weight (LBW: <2500 g); small for gesta-
tional age (SGA, <10th percentile for gestational age);
intrauterine growth restriction (IUGR, <3rd percentile for
gestational age); large for gestational age (LGA, >90th per-
centile for gestational age); and macrosomia (>4,000 g).
Gestational age will be determined by date of the last
menstrual period and 18-week ultrasound.
Dietary measurements
At 14 weeks gestation (run-in phase) all women will
firstly complete a questionnaire on pregnancy food
intake. This questionnaire will capture information on
how/if they have changed their diet since identifying
they are pregnant. Weeks of gestation will be recorded
for both the time they found out they were pregnant and
current gestation. Questions on how they have changed
their diet will be asked, including reference to each of
the food groups in the Australian Dietary Guidelines,
plus alcohol consumption, soft cheese and deli meat
consumption (to assess risk of listeria), fish consump-
tion, and intake of non-core foods, such as takeaway
foods. Next, all women will complete the standard
Cancer Council of Victoria’s Dietary Questionnaire for
Epidemiological Studies (FFQ) to assess food intake 1
year prior to pregnancy. A 24-hr recall will be adminis-
tered at the face-to-face visits and over the phone. This
questionnaire asks for detailed information on meals
and snacks consumed 24 hr prior to the clinic visit. Data
will be entered into the Foodworks (Xyris, Brisbane)
database. Throughout the 12-week study, all women will
be required to complete a weekly count of the average
number of servings of each food group consumed
according to the Australian Dietary Guidelines. Eating
habits will be measured using the eating habits subscale
from the Project EAT Survey [49]. All items are scored
on a scale of 1 to 5 and summed, a higher score indicat-
ing less desirable eating habits.
Questionnaires
A questionnaire on passive smoking will be included, as
passive smoking can play a role in asthma severity and
antioxidant status. A passive-smoking questionnaire pre-
viously used by our colleagues [46] will be carried out at
baseline and at the middle and end of the 12-week study.
A validated, 10-minute self-administered physical activity
questionnaire for pregnant women [50] will also be con-
ducted and modified to cover the prior weeks of physical
activity (Table 1). Significant differences in baseline
passive smoking or physical activity variables will be
controlled for in the analyses.
Biochemistry
At each clinic visit, 20 mL of non-fasting, whole blood will
be taken from the median cubital vein and collected into
an ethylenediaminetetraacetic acid (EDTA)-coated tube.
Plasma carotenoids, including lycopene, lutein, β-cryptox-
anthin, α-carotene, and β-carotene will be analyzed using
high-performance liquid chromatography [51]. Plasma in-
flammatory markers (IL-1, IL6, TNF-α) will be measured
using standard ELISA assay procedures (Cayman Chemical,
Ann Arbor, MI, USA). Total antioxidant potential will be
measured using calorimetric assay (Sapphire Bioscience,
Waterloo, NSW, Australia). Plasma zinc will be measured
using atomic absorption spectrometry. Erythrocyte super-
oxide dismutase activity will be measured by colorimetric
assay (Bioxytech; OXIS International, Portland, OR, USA).
Total fatty acids in red blood cell membranes will be ana-
lyzed by gas chromatography [52].
Achieving compliance
Compliance with the intervention is critical to the suc-
cess of this project and will be achieved using behavior
change strategies including self-monitoring, and regular
phone calls for dietary counseling. The $30 shopping
voucher will be used to assist compliance as this popula-
tion typically has a low intake of antioxidant-rich foods.
All participants will complete a food group diary and
regular 24-hr dietary recalls, and the intervention group
will have additional dietary education during the phone
calls. We have previously achieved good compliance
with this intervention using similar strategies [10,11]. To
monitor compliance, we will measure blood carotenoids
for the increased fruit and vegetable consumption. We
will also collect the shopping voucher receipts and docu-
ment amounts of foods purchased.
Randomization
The randomization schedule will be created by an inde-
pendent statistician using ralloc.ado version 3.6.1 in Stata
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version 11.1. Randomization will be stratified by pre-
pregnancy asthma severity (based on the Global Initiative
for Asthma guidelines) and body mass index.
Sample size and recruitment
The primary outcome for this study is asthma control
(ACQ6). In our previous study, we saw a change in
asthma control of 0.4 (SD = 0.9) following 10 days on a
low-antioxidant diet [10]. In this trial of longer duration
we expect to see a clinically significant change in ACQ
of 0.5. Using PS.exe (Power and sample size calculation,
version 3.0.43) with two-tailed t-tests at 80% power, we
have determined that a sample size of 52 completions
per group is required. The previous trial achieved 78%
retention; however, 20% were removed from the analysis
due to non-compliance. Therefore, we will recruit 168
women so that 104 women (52 per group) will complete
the study and be included in the analysis. There are
3,600 births per year at LMH and at least 12% of the
women have asthma. From our previous cohort studies
at the LMH, we have found that approximately 360
pregnant women have a complication of asthma. We will
need to recruit a minimum 84 per year (including 20%
low compliance + 22% drop out) to complete the study
within 3 years. We believe capturing this number of
women per year is feasible, given we only need to recruit
23% of the asthmatic women presenting to the Antenatal
Clinic.
Statistical analyses
All statistics will be performed using SPSS version 20.0
(SPSS, Inc., Chicago, IL, USA). Frequencies and descrip-
tive data for the study population will be reported as
mean (SD) or between groups as mean (± standard error
of the mean). Prior to hypothesis testing, the distribution
of the data will be examined for normality. Any skewed
data will be natural log-transformed. Outcome compari-
sons will be made according to the treatment allocation
at randomization on an intention-to-treat basis. Both
adjusted and unadjusted analyses will be carried out.
Continuous variables with repeated measurements (that
is, ACQ6 score, blood results) will be analyzed using a
generalized linear mixed model with a random intercept
for individuals, to account for repeated measurements.
Planned sub-analyses will be undertaken to assess the
effects of asthma severity, asthma control, forced ex-
piratory volume in 1 second (FEV1) and FENO, on
the primary and secondary outcomes. We will ac-
count for changes in ICS by assessing ICS intake as a
cumulative dose over the study period. Differences be-
tween groups in time to exacerbation will be analyzed
using Kaplan-Meier curves. All tests will be conducted
two-sided, and a P-value <0.05 will be considered
statistically significant.
Discussion
Pregnant women have heightened inflammation and oxi-
dative stress and this is further compounded by asthma.
The lungs have endogenous antioxidant mechanisms to
combat the damaging effects of reactive oxygen species;
however, as levels of antioxidants in the lungs as well as
in circulation are reduced in asthmatic patients [4-6],
balancing the oxidant-antioxidant system may ame-
liorate oxidative stress in pregnancies complicated by
asthma.
In non-pregnant asthmatic adults, epidemiological
studies provide mixed evidence for the use of dietary
antioxidant vitamins or antioxidant-rich foods to improve
asthma. Current evidence from RCTs also suggests that
supplementation with individual antioxidants is not bene-
ficial in improving lung function or asthma control. Only
one RCT has examined the effect of manipulating antioxi-
dant intake, via the consumption of whole foods, on
asthma outcomes and lung function in asthmatic adults
[11]. Specifically, compared to a high fruit (≥2 servings/d)
and vegetable (≥5 servings/d) diet for 14 weeks, the asth-
matic subjects who consumed a low fruit (<1 serving/d)
and vegetable (<2 servings/d) diet had a 2.26-fold in-
creased risk of asthma exacerbation [11]. No studies
have assessed antioxidant supplementation or dietary
modification with antioxidant-rich foods in pregnant
women with asthma. It is likely that these women would
benefit most from such an intervention in order to improve
asthma control and potentially improve birth outcomes.
The proposed study aims to determine whether con-
sumption of an antioxidant-rich diet for 12 weeks,
including fruits, vegetables, lean meat and wholegrains,
will improve asthma control and improve antioxidant
concentrations, reduce oxidative stress markers, and
reduce the risk of asthma exacerbation, compared to
standard dietary intake during pregnancy. The necessity
of adherence to a diet rich in antioxidants in this study
is crucial. However, we will use behavior-change strat-
egies such as self-monitoring and regular phone calls for
dietary counseling. This will ensure that all women have
regular contact with the researchers to achieve adher-
ence, as well as to ask any questions related to problems
in achieving adherence. All women will complete a
weekly food group diary to promote adherence and
women in the intervention group will also have fort-
nightly phone call sessions with the nutritionist who will
provide education on meal plans and antioxidant-rich
food options. All of these strategies will be in place to
ensure a successful intervention.
This 12-week study aims to improve asthma control,
maternal plasma concentrations of antioxidants and
decrease rates of asthma exacerbations. These outcomes
are significant because asthma is the most prevalent
condition to complicate pregnancies, and asthma in
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pregnancy leads to poor maternal, neonatal and infant
health outcomes. Our research will provide the first evi-
dence to show that, in pregnancy, dietary antioxidant
consumption is a key modifier of clinical asthma status.
Our research will provide the first step towards developing
larger clinical trials through which increased antioxidant-
rich foods will lead to a reduced risk of low birth weight,
growth restriction, preterm delivery, and preeclampsia, via
an improvement in asthma control; this will also poten-
tially reduce the risk for atopic disease in childhood. These
outcomes will provide further evidence to show that sig-
nificantly increasing dietary antioxidant intakes positively
impacts the rising prevalence of asthma. The findings
from our study will inform the development of asthma
management resources for pregnant women, through
which the increased consumption of antioxidant-rich
foods can be included in management protocols. Dietary
modifications, which importantly, are in line with current
national guidelines, should be a relatively simple and
practical approach towards managing asthma control.
Therefore, whilst the study will be conducted in women





ACQ6: asthma control questionnaire 6; AMEA: asthma management and
education advice; ANCTR: Australia and New Zealand Clinical Trials Registry;
BP: blood pressure; ELISA: enzyme-linked immunosorbent assay;
FENO: fraction of exhaled nitric oxide; FEV1: forced expiratory volume in 1
second; FFQ: food frequency questionnaire; F + V: fruit and vegetable;
ICS: inhaled corticosteroids; IL: interleukin; IUGR: intrauterine growth
restriction; LBW: low birth weight; LGA: large for gestational age; LMH: Lyell
McEwin Hospital; RCT: randomized controlled trial; SGA: small for gestational
age; TNF: tumor necrosis factor.
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